Your browser doesn't support javascript.
loading
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.
Edmondson, R J; Crosbie, E J; Nickkho-Amiry, M; Kaufmann, A; Stelloo, E; Nijman, H W; Leary, A; Auguste, A; Mileshkin, L; Pollock, P; MacKay, H J; Powell, M E; Bosse, T; Creutzberg, C L; Kitchener, H C.
Afiliación
  • Edmondson RJ; Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust,
  • Crosbie EJ; Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust,
  • Nickkho-Amiry M; Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Kaufmann A; Northern Institute of Cancer Research, Newcastle University, UK.
  • Stelloo E; Department of Pathology, Leiden University Medical Center, Leiden, The Netherland.
  • Nijman HW; Department of Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Leary A; INSERM U981, Department of Medicine, Gynecology Unit, Gustave Roussy, Villejuif, France.
  • Auguste A; INSERM U981, Department of Medicine, Gynecology Unit, Gustave Roussy, Villejuif, France.
  • Mileshkin L; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia.
  • Pollock P; Queensland University of Technology, (QUT), Translational Research Institute, Brisbane, Australia.
  • MacKay HJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Princess Margaret Hospital/University Health Network, University of Toronto, Canada.
  • Powell ME; Department of Clinical Oncology, Barts Health NHS Trust, London, UK.
  • Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherland.
  • Creutzberg CL; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kitchener HC; Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
Gynecol Oncol ; 146(2): 327-333, 2017 08.
Article en En | MEDLINE | ID: mdl-28511869
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteína p53 Supresora de Tumor / Neoplasias Endometriales / Neoplasias Quísticas, Mucinosas y Serosas / Carcinoma Endometrioide / Adenocarcinoma de Células Claras / Proteínas Supresoras de Tumor / Proteínas Proto-Oncogénicas c-mdm2 / Inhibidor p21 de las Quinasas Dependientes de la Ciclina Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteína p53 Supresora de Tumor / Neoplasias Endometriales / Neoplasias Quísticas, Mucinosas y Serosas / Carcinoma Endometrioide / Adenocarcinoma de Células Claras / Proteínas Supresoras de Tumor / Proteínas Proto-Oncogénicas c-mdm2 / Inhibidor p21 de las Quinasas Dependientes de la Ciclina Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article